Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03429439Unknown
Randomised, open-label trial in Chronic Hepatitis B (CHB) (2 arms), sponsored by Xiamen University Zhongshan Hospital. Primary endpoint: Change of serum hepatitis B virus e antigen level at 6 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03429439.